After further researching, the mechanism might be that F. nucleatum would target toll-like-receptor-4 (TLR-4) and myeloid differentiation factor 88 (MyD88) innate immune signals and the certain microRNAs, which subsequently drove the autophagy pathway and thus influenced CRC chemotherapeutic response (9). This evidence concerns the gene MYD88 and colorectal carcinoma.